n acetyl l carnitine examine Oral Acetyl-L-Carnitine treatment in hepatic encephalopathy: view of evidence-based medicine A 1-year multicenter placebo-controlled study
Description
May 3 2020;9(2)doi:10.3390/ht9020012

Selective inhibition of FOXO1 activator/repressor balance modulates hepatic glucose handling

doi: 10.1172/JCI69636 163 CloonanSMLamHCRyterSWChoiAM
Sawicka, A
